H. Alexander

H. Alexander, M. Deraco, K. Turaga, 2017, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy.

H. Alexander, P. Sugarbaker, M. Hesdorffer, 2016, Journal of oncology practice.

Diagnosis and management of patients with malignant peritoneal mesothelioma.

A. Burke, H. Alexander, 2016, Journal of gastrointestinal oncology.

Surgery to cure the Zollinger-Ellison syndrome.

J. Norton, J. Doppman, D. Fraker, 1999, The New England journal of medicine.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms

R. Yantiss, J. Fleshman, N. Ahuja, 2020, Annals of Surgical Oncology.

An asterisk indicates reviewers who have evaluated three or more manuscripts in 2012.

David Ball, Ash A. Alizadeh, David A. August, 2013 .

Isolated Hepatic Perfusion with High-Dose Melphalan Results in Immediate Alterations in Tumor Gene Expression in Patients with Metastatic Ocular Melanoma

H. Alexander, D. Bartlett, M. Hughes, 2010, Annals of Surgical Oncology.

Surgery in Zollinger‐Ellison Syndrome Alters the Natural History of Gastrinoma

J. Norton, D. Fraker, R. Jensen, 1994, Annals of surgery.

Porcelain gallbladder and cancer: ethnicity explains a discrepant literature?

H. Alexander, S. Cunningham, H. Alexander, 2007, The American journal of medicine.

Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver.

D. Fraker, S. Rosenberg, H. Alexander, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

False-positive iodine-131 whole-body scans due to cholecystitis and sebaceous cyst.

D. Fraker, F. Brucker-Davis, B. Weintraub, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.

Jeffrey E. Lee, M. Ross, D. Fraker, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Venographic surveillance of tunneled venous access devices in adult oncology patients

J. Doppman, H. Alexander, H. Alexander, 1995, Annals of Surgical Oncology.

Substrate alterations in a sarcoma-bearing rat model: effect of tumor growth and resection.

M. Burt, H. Alexander, H. Alexander, 1990, The Journal of surgical research.

Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.

J. Norton, J. Doppman, D. Fraker, 1998, Annals of surgery.

A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.

S. Libutti, D. Fraker, H. Alexander, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms.

S. Libutti, P. Choyke, W. Linehan, 2012, Surgery.

CLINICAL, GENETIC AND RADIOGRAPHIC ANALYSIS OF 108 PATIENTS WITH VON HIPPEL-LINDAU DISEASE (vHL) MANIFESTED BY PANCREATIC NEUROENDOCRINE TUMORS (PNETs)

P. Choyke, W. Linehan, H. Alexander, 2019 .

Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations.

S K Libutti, P L Choyke, D L Bartlett, 1998, Surgery.

Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs).

Peter L Choyke, W Marston Linehan, S. Libutti, 2007, Surgery.

Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas.

S. Libutti, T. Shawker, J. Doppman, 1997, Surgery.

EXTENSIVE PERSONAL EXPERIENCE Plasma Proinsulin-Like Component in Insulinoma: A %-Year Experience

J. Norton, J. Doppman, D. Fraker, 1995 .

Rapid progression of a pregnancy-associated intra-abdominal desmoid tumor in the post-partum period: A case report

H. Alexander, W. Twaddell, S. Kesmodel, 2016, International journal of surgery case reports.

The YAP1 Signaling Inhibitors, Verteporfin and CA3, Suppress the Mesothelioma Cancer Stem Cell Phenotype

H. Alexander, R. Eckert, E. Rorke, 2019, Molecular Cancer Research.

Current concepts in the evaluation and treatment of patients with diffuse malignant peritoneal mesothelioma.

H. Alexander, Sheelu Varghese, K. Turner, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Heterogeneous gland size in sporadic multiple gland parathyroid hyperplasia.

S. Libutti, J. Doppman, H. Alexander, 1999, Journal of the American College of Surgeons.

Management and Outcome of Patients With Sporadic Gastrinoma Arising in the Duodenum

S. Libutti, J. Norton, R. Jensen, 2003, Annals of surgery.

Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1.

J. Norton, D. Fraker, R. Jensen, 1995, Surgery.

Comparison of Surgical Results in Patients With Advanced and Limited Disease With Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison Syndrome

J. Norton, D. Fraker, D. Venzon, 2001, Annals of surgery.

Forty-eight-hour fast: the diagnostic test for insulinoma.

S. Libutti, J. Doppman, P. Gorden, 2000, The Journal of clinical endocrinology and metabolism.

Prognostic V alue o f I nitial F asting S erum G astrin L evels in P atients W ith Z ollinger-Elliso n S yndrome

S. Libutti, J. Norton, J. Doppman, 2001 .

Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.

D. Fraker, S. Rosenberg, H. Alexander, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective Study of Surgery for Primary Hyperparathyroidism (HPT) in Multiple Endocrine Neoplasia-Type 1 and Zollinger-Ellison Syndrome: Long-Term Outcome of a More Virulent Form of HPT

S. Libutti, J. Norton, D. Fraker, 2008, Annals of surgery.

Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1.

S. Libutti, J. Norton, R. Jensen, 2003, Surgery.

Hyperparathyroidism in hereditary syndromes: special expressions and special managements.

F. Collins, S. Libutti, W. Simonds, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1.

S. Libutti, J. Norton, D. Fraker, 2001, Surgery.

Upper Extremity Impedance Plethysmography in Patients with Venous Access Devices

H. Gralnick, H. Alexander, E. Whitman, 1994, Thrombosis and Haemostasis.

Value of Surgery in Patients With Negative Imaging and Sporadic Zollinger-Ellison Syndrome

J. Norton, D. Fraker, R. Jensen, 2012, Annals of surgery.

Does the Use of Routine Duodenotomy (DUODX) Affect Rate of Cure, Development of Liver Metastases, or Survival in Patients With Zollinger-Ellison Syndrome?

J. Norton, D. Fraker, R. Jensen, 2004, Annals of surgery.

Possible Primary Lymph Node Gastrinoma: Occurrence, Natural History, and Predictive Factors: A Prospective Study

J. Norton, D. Fraker, R. Jensen, 2003, Annals of surgery.

Expression of PD-L1 in Patients With Malignant Peritoneal Mesothelioma: A Pilot Study.

H. Alexander, R. Langan, D. Moore, 2022, The Journal of surgical research.

Regional Treatment Options for Patients With Ocular Melanoma Metastatic to the Liver

H. Alexander, J. Pingpank, E. Feldman, 2004, Annals of Surgical Oncology.

Consensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Patients in the United States

N. Petrelli, Benjamin D. L. Li, G. Nash, 2013, Annals of Surgical Oncology.

Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma.

S. Libutti, N. Hanna, H. Alexander, 2013, Surgery.

Peritoneal Metastases from Malignant Mesothelioma.

H. Alexander, Claire Y Li, 2018, Surgical oncology clinics of North America.

Current Management and Future Opportunities for Peritoneal Metastases: Peritoneal Mesothelioma

H. Alexander, T. Kennedy, Claire Y Li, 2018, Annals of Surgical Oncology.

Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients

A. Burke, H. Alexander, Paul N. Staats, 2014, Pathology.

Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy

A. Burke, H. Alexander, Michael Lee, 2013, Pathology.

Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma.

N. Hanna, H. Alexander, J. Pingpank, 2007, Cancer treatment and research.

A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer

E. Trimble, E. Zuhowski, M. Egorin, 1999, Cancer Chemotherapy and Pharmacology.

Localization and operative management of undescended parathyroid adenomas in patients with persistent primary hyperparathyroidism.

J. Norton, T. Shawker, J. Doppman, 1994, Surgery.

Thymidylate synthase protein expression: Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinoma.

S. Steinberg, D. Fraker, P. Johnston, 1995, The cancer journal from Scientific American.

A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma.

J. Norton, T. Shawker, J. Doppman, 1996, Annals of surgery.

Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three-week course chemoradiotherapy using capecitabine-based versus gemcitabine-based concurrent chemotherapy.

H. Alexander, D. August, S. Jabbour, 2021, Journal of gastrointestinal oncology.

Management of Extremity Recurrences After Complete Responses to Isolated Limb Perfusion in Patients With Melanoma

A. Feldman, S. Libutti, D. Fraker, 1999, Annals of Surgical Oncology.

Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease.

S. Steinberg, S. Libutti, W. Linehan, 2010, Journal of the American College of Surgeons.

National Cancer Institute Experience with Regional Therapy for Unresectable Primary and Metastatic Cancer of the Liver or Peritoneal Cavity

S. Libutti, H. Alexander, D. Bartlett, 2000 .

Treatment of peritoneal carcinomatosis by continuous hyperthermic peritoneal perfusion with cisplatin.

D. Fraker, H. Alexander, 1996, Cancer treatment and research.

Isolated hepatic perfusion: a potentially effective treatment for patients with metastatic or primary cancers confined to the liver.

H. Alexander, D. Bartlett, S. Libutti, 1998, The cancer journal from Scientific American.

Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms.

H. Alexander, D. Bartlett, E. Turner, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

The use of tumour necrosis factor (TNF) in isolated perfusion: results and side effects. The NCI results.

D. Fraker, H. Alexander, 1994, Melanoma research.

Plasma proinsulin-like component in insulinoma: a 25-year experience.

J. Norton, J. Doppman, D. Fraker, 1995, The Journal of clinical endocrinology and metabolism.

Gastrinoma: sporadic and familial disease.

S. Libutti, H. Alexander, 2006, Surgical oncology clinics of North America.

Palliative interventions in patients with peritoneal metastases and malignant bowel obstruction.

H. Alexander, E. Bellavance, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective.

H. Alexander, G. Karakousis, M. Neuwirth, 2016, Journal of gastrointestinal oncology.

Outcomes Following Major Oncologic Operations for Non-AIDS-Defining Cancers in the HIV Population: A Matched Comparison to the General Population

S. Libutti, H. Alexander, D. August, 2019, World Journal of Surgery.

Eicosanoids and The Pathophysiology of Sepsis and Trauma

M. Fink, H. Alexander, J. Fletcher, 1987 .

Surgery for Peritoneal Mesothelioma

H. Alexander, Sheelu Varghese, K. Turner, 2011, Current treatment options in oncology.

Surgery for Peritoneal

H. Alexander, Sheelu Varghese, Mesothelioma M. Turner, 2011 .

Clinical and genetic analysis of patients with pancreatic neuroendocrine tumours associated with von Hippel‐Lindau disease

S. Libutti, P. Choyke, R. Klausner, 2000 .

Hormonal responses to graded surgical stress.

R. Smallridge, M. Fink, H. Alexander, 1987, Archives of internal medicine.

Is reoperation for gastrinoma excision indicated in Zollinger-Ellison syndrome?

J. Norton, J. Doppman, D. Fraker, 1996, Surgery.

NO•/RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancer

T. Ried, A. Lal, Jian Wang, 2020, International journal of cancer.

Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

F. Galateau-Sallé, M. Zauderer, V. Rusch, 2019, CA: a cancer journal for clinicians.

Site-Specific Gene Expression Profiles and Novel Molecular Prognostic Factors in Patients with Lower Gastrointestinal Adenocarcinoma Diffusely Metastatic to Liver or Peritoneum

H. Alexander, Hui Xu, J. Pingpank, 2007, Annals of Surgical Oncology.

Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.

Seth M Steinberg, Andrew L Feldman, S. Steinberg, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Limited survival in patients with carcinomatosis from foregut malignancies after cytoreduction and continuous hyperthermic peritoneal perfusion

S. Libutti, H. Alexander, D. Bartlett, 2005, Journal of Gastrointestinal Surgery.

Results of heterotopic parathyroid autotransplantation: a 13-year experience.

A. Feldman, S. Libutti, J. Norton, 1999, Surgery.

Hyperthermic Regional Perfusion for Melanoma of the Limbs

D. Fraker, D. Tyler, H. Alexander, 2018, Cutaneous Melanoma.

Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer

Jochen Gaedcke, Nader Hanna, Thomas Ried, 2013, Clinical Cancer Research.

Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer

A. Maitra, T. Ried, S. Hussain, 2013 .

Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasia.

S. Steinberg, S. Libutti, N. Patronas, 2008, Surgery.

Surgical management of Cushing Syndrome secondary to micronodular adrenal hyperplasia

S. Steinberg, S. Libutti, N. Patronas, 2008 .

Surgical Treatment of Malignant Peritoneal Mesothelioma: Past, Present, and Future

H. Alexander, 2009, Annals of surgical oncology.

A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.

A. Schetter, T. Ried, J. Werner, 2016, Cancer research.

Evaluation of low-dose fractionated radiation therapy as a chemopotentiator of gemcitabine in advanced pancreatic cancer: results from an international multi-institutional phase II trial

N. Hanna, H. Alexander, D. Laheru, 2015, Journal of Radiation Oncology.

Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database

D. Carpizo, H. Alexander, D. August, 2020, Surgery open science.

Activation of the phosphoinositide‐3‐kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesothelioma

S. Steinberg, S. Libutti, H. Alexander, 2011, Cancer.

A Prospective Study of 2-[18F] Fluoro-2-Deoxy-D-Glucose/Positron Emission Tomography Scan, 99mTc-Labeled Arcitumomab (CEA-Scan), and Blind Second-Look Laparotomy for Detecting Colon Cancer Recurrence in Patients With Increasing Carcinoembryonic Antigen Levels

S. Libutti, P. Choyke, S. Bacharach, 2001, Annals of Surgical Oncology.

A prospective evaluation of laparoscopic exploration with intraoperative ultrasound as a technique for localizing sporadic insulinomas.

S. Libutti, T. Shawker, P. Gorden, 2005, Surgery.

Laparoscopic adrenalectomy: a new standard of care.

L. Kavoussi, W. Linehan, D. Fraker, 1997, Urology.

Localization of Insulinomas to Regions of the Pancreas by Intra-arterial Stimulation with Calcium

D. Fraker, H. Alexander, P. Gorden, 1995, Annals of Internal Medicine.

Use of preoperative fine-needle aspiration in patients undergoing reoperation for primary hyperparathyroidism.

J. Norton, T. Shawker, J. Doppman, 1994, Surgery.

Hypocalcemic stimulation and nonselective venous sampling for localizing parathyroid adenomas: work in progress.

S. Libutti, J. Doppman, H. Alexander, 1998, Radiology.

The role of thyroid resection during reoperation for persistent or recurrent hyperparathyroidism.

S. Libutti, J. Doppman, D. Fraker, 1997, Surgery.

Parathyroid adenoma within the vagus nerve.

T. Shawker, J. Doppman, D. Fraker, 1994, AJR. American journal of roentgenology.

Isolated hepatic perfusion for patients with liver metastases

H. Alexander, S. Reddy, S. Kesmodel, 2014, Therapeutic advances in medical oncology.

Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver.

S. Steinberg, S. Libutti, C. Helsabeck, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Analysis o f F actors A ssociated W ith O utcome i n P atients W ith Malignant P eritoneal M esothelioma U ndergoing S urgical Debulking a nd I ntraperitoneal C hemotherapy

S. Steinberg, A. Feldman, S. Libutti, 2003 .

Factors Affecting Survival After Complete Response to Isolated Limb Perfusion in Patients With In-Transit Melanoma

S. Steinberg, S. Libutti, D. Fraker, 2001, Annals of Surgical Oncology.

Role of preoperative localization and intraoperative localization maneuvers including intraoperative PTH assay determination for patients with persistent or recurrent hyperparathyroidism.

P. Choyke, H. Alexander, Clara C. Chen, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Successful outcome after surgical management in two cases of the "painful variant" of Hashimoto's thyroiditis.

D. Papanicolaou, S. Libutti, M. Merino, 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism.

S. Libutti, A. Remaley, H. Alexander, 1999, Surgery.

Utility of rapid intraoperative parathyroid hormone assay to predict severe postoperative hypocalcemia after reoperation for hyperparathyroidism.

S. Libutti, D. Venzon, W. Simonds, 2002, Surgery.

Role of preoperative iodocholesterol scintiscanning in patients undergoing adrenalectomy for Cushing's syndrome.

J. Norton, J. Doppman, D. Fraker, 1995, Surgery.

Peak stimulated insulin secretion is associated with specific changes in gene expression profiles in sporadic insulinomas.

S. Libutti, D. Harlan, P. Gorden, 2003, Surgery.

Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.

Yingdong Zhao, Richard Simon, Paul H Duray, 2002, Cancer research.

Journal of Translational Medicine Interleukin-1 and Cancer Progression: the Emerging Role of Interleukin-1 Receptor Antagonist as a Novel Therapeutic Agent in Cancer Treatment

H. Alexander, H. Alexander, Hui Xu, 2022 .

FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer.

T. Ried, S. Hussain, Peijun He, 2013, Cancer research.

Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer

A. Schetter, T. Ried, S. Hussain, 2016, Clinical Cancer Research.

Assessing the immediate impact of COVID‐19 on surgical oncology practice: Experience from an NCI‐designated Comprehensive Cancer Center in the Northeastern United States

H. Alexander, A. Berger, S. Rehman, 2021, Journal of surgical oncology.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors

R. Yantiss, J. Fleshman, N. Ahuja, 2020, Annals of Surgical Oncology.

The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors

R. Yantiss, J. Fleshman, N. Ahuja, 2020, Cancer.

Operative management of islet-cell tumors arising in the head of the pancreas.

S. Libutti, J. Norton, T. Shawker, 1998, Surgery.

Isolated breast metastases from gastrointestinal carcinomas: Report of two cases

H. Alexander, A. Turnbull, P. Rosen, 1989, Journal of surgical oncology.

Multipotent Cancer Stem Cells Derived from Human Malignant Peritoneal Mesothelioma Promote Tumorigenesis

H. Alexander, R. Whipple, Stuart S. Martin, 2012, PloS one.

Use of tumor necrosis factor in isolated hepatic perfusion.

D. Fraker, H. Alexander, A. Thom, 1994, Circulatory shock.

Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan.

D. Fraker, S. Rosenberg, W. Barker, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Isolated limb perfusion with high-dose tumor necrosis factor for extremity melanoma and sarcoma.

D. Fraker, H. Alexander, 1994, Important advances in oncology.

Isolation Perfusion of the Liver

H. Alexander, H. Alexander, N. M. Carroll, 2002, Cancer journal.

Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters.

S. Steinberg, S. Libutti, D. Fraker, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver: Open and Percutaneous Techniques.

H. Alexander, H. Alexander, Virginia R Devi-Chou, 2021, Surgical oncology clinics of North America.

Hepatic Perfusion: Surgical and Catheter

H. Alexander, S. Greco, Stephanie H. Greco, 2019 .

Development of isolated hepatic perfusion for patients who have unresectable hepatic malignancies.

H. Alexander, A. Jones, 2008, Surgical oncology clinics of North America.

Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver.

S. Libutti, H. Alexander, D. Bartlett, 2000, The oncologist.

TNF-based isolated hepatic perfusion.

H. Alexander, E. Bellavance, 2009, Frontiers in bioscience.

Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor.

D. Fraker, S. Rosenberg, H. Alexander, 1995, The cancer journal from Scientific American.

Isolated Hepatic Perfusion for the Treatment of Patients With Colorectal Cancer Liver Metastases After Irinotecan-Based Therapy

S. Libutti, C. Helsabeck, H. Alexander, 2005, Annals of Surgical Oncology.

Bilateral adrenalectomy for Cushing's syndrome. Anterior versus posterior surgical approach.

J. Norton, D. Fraker, H. Alexander, 1997, Annals of surgery.

A phase III random assignment trial comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to standard of care for patients with hepatic metastases from metastatic ocular or cutaneous melanoma.

C. Nutting, H. Alexander, M. Hughes, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A prospective analysis of the frequency, location, and curability of ectopic (nonpancreaticoduodenal, nonnodal) gastrinoma.

J. Norton, J. Doppman, D. Fraker, 1997, Surgery.

Isolated hepatic perfusion: treating unresectable liver metastases.

H. Alexander, J. Pingpank, J. Farma, 2006, Advances in experimental medicine and biology.

Development of Isolated Hepatic Perfusion via the Operative and Percutaneous Techniques for Patients With Isolated and Unresectable Liver Metastases

H. Alexander, C. Butler, 2010, Cancer journal.

Concepts of Regional Therapies for Advanced Malignancy

H. Alexander, D. Bartlett, T. Gamblin, 2012, Annals of Surgical Oncology.

Hyperthermic isolated hepatic perfusion for the treatment of unresectable cancers confined to the liver

H. Alexander, N. M. Carroll, 2002, Journal of surgical oncology.

9304 ORAL Percutaneous Hepatic Perfusion (PHP) Vs. Best Alternative Care (BAC) for Patients (pts) With Melanoma Liver Metastases – Efficacy Update of the Phase 3 Trial (NCT00324727)

C. Nutting, H. Alexander, M. Hughes, 2011 .

A Pilot Feasibility Study of TNFerade™ Biologic with Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer

S. Steinberg, S. Libutti, K. Camphausen, 2011, Oncology.

The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations

R. Yantiss, J. Fleshman, N. Ahuja, 2020, Annals of Surgical Oncology.

The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations

R. Yantiss, J. Fleshman, N. Ahuja, 2020, Cancer.

Needle-localized mammographic lesions. Results and evolving treatment strategy.

D. Dershaw, H. Alexander, D. Kinne, 1990, Archives of surgery.

Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis

M. Zhan, S. El-Kamary, H. Alexander, 2014, Medical Oncology.

Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience.

S. Libutti, H. Alexander, P. Gorden, 2009, The Journal of clinical endocrinology and metabolism.

The Chicago Consensus Guidelines for peritoneal surface malignancies: Introduction

N. Ahuja, G. Nash, J. Esquivel, 2020, Cancer.

The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma

R. Yantiss, J. Fleshman, N. Ahuja, 2020, Cancer.

The Chicago Consensus on peritoneal surface malignancies: Standards

R. Yantiss, J. Fleshman, N. Ahuja, 2020, Cancer.

Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure.

S. Libutti, T. Shawker, H. Alexander, 2002, Journal of the American College of Surgeons.

Apparent lymph node primary gastrinoma.

J. Norton, D. Fraker, R. Jensen, 1994, Surgery.

Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas

S. Libutti, E. Zuhowski, M. Egorin, 2008, Cancer Chemotherapy and Pharmacology.

Disparities in utilization of services for racial and ethnic minorities with hepatocellular carcinoma associated with hepatitis C.

H. Alexander, D. August, R. Langan, 2020, Surgery.

Current Concepts in the Diagnosis and Management of Patients With Malignant Peritoneal Mesothelioma

H. Alexander, E. Ginalis, Claire Y Li, 2019, Multidisciplinary Cancer Investigation.

Persistent Primary Hyperparathyroidism Caused by Adenomas Identified in Pharyngeal or Adjacent Structures

S. Libutti, J. Doppman, H. Alexander, 2003, World Journal of Surgery.

High cervical intravagal hypercellular parathyroid gland as the etiology of severe persistent primary hyperparathyroidism.

T. Shawker, J. Doppman, D. Fraker, 1995, The American surgeon.

Role of surgery in management of adrenocorticotropic hormone-producing islet cell tumors of the pancreas.

J. Norton, J. Doppman, D. Fraker, 1995, Surgery.

Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract

Deshka S. Foster, J. Norton, D. Fraker, 2018, JAMA surgery.

Cytoreduction and hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis dissemination from colorectal cancer

H. Alexander, K. Turner, 2012 .

Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation

H. Alexander, R. Eckert, J. Friedberg, 2018, Oncotarget.

Surgical treatment of localized gastrinoma within the liver: a prospective study.

J. Norton, J. Doppman, D. Fraker, 1998, Surgery.

A Motion for Cautious Optimism in the Treatment of Patients With Ocular Melanoma: The Ayes Have It

H. Alexander, 2005, Annals of surgical oncology.

Nesidioblastosis in Adults: A Clinical Enigmag

S. Libutti, H. Alexander, D. Bartlett, 2001 .

Medical and surgical care of mesothelioma patients and their relatives carrying germline BAP1 mutations.

Chuong D. Hoang, V. Rusch, S. Pastorino, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy.

H. Alexander, G. Karakousis, 2015, Journal of gastrointestinal oncology.

The History of Isolated Hepatic Perfusion for Liver Metastases and Current Indications for Use

H. Alexander, T. Gamblin, C. Clarke, 2019 .

1105PVEMURAFENIB FOR BRAF V600 MUTATED ADVANCED MELANOMA: RESULTS OF TREATMENT BEYOND PROGRESSION.

Y. S. Kim, Su Jin Lee, J. Utikal, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.

S. Libutti, A. Dackiw, M. Zeiger, 2005, Surgery.

Peritoneal mesothelioma

H. Alexander, A. Greenbaum, 2020, Translational lung cancer research.

Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison.

S. Libutti, P. Choyke, W. Linehan, 2002, Radiology.